Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 657907, 9 pages
http://dx.doi.org/10.1155/2015/657907
Clinical Study

Systemic Autoimmune, Rheumatic Diseases and Coinciding Psoriasis: Data from a Large Single-Centre Registry and Review of the Literature

1National Institute of Rheumatology and Physiotherapy, Frankel Leó Utca 38-40, Budapest 1023, Hungary
2Institute of Immunology, Rikshospitalet, Oslo University Hospital, 0027 Oslo, Norway

Received 14 September 2014; Accepted 10 November 2014

Academic Editor: Yrjö Konttinen

Copyright © 2015 Anna Bazsó et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. K. Raychaudhuri, E. Maverakis, and S. P. Raychaudhuri, “Diagnosis and classification of psoriasis,” Autoimmunity Reviews, vol. 13, no. 4-5, pp. 490–495, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Wu, T. U. Nguyen, K. Y. T. Poon, and L. J. Herrinton, “The association of psoriasis with autoimmune diseases,” Journal of the American Academy of Dermatology, vol. 67, no. 5, pp. 924–930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Jones, N. Yawalkar, K.-Y. Suh, S. Sadat, B. Rich, and T. S. Kupper, “Identification of autoantigens in psoriatic plaques using expression cloning,” Journal of Investigative Dermatology, vol. 123, no. 1, pp. 93–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Y. M. G. Fung, D. J. Smyth, J. M. M. Howson et al., “Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus,” Genes & Immunity, vol. 10, no. 2, pp. 188–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativ,” Annals of the Rheumatic Diseases, vol. 62, no. 9, pp. 1580–1588, 2010. View at Publisher · View at Google Scholar
  6. S. C. Shiboski, C. H. Shiboski, L. A. Criswell et al., “American College of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort,” Arthritis Care and Research, vol. 64, no. 4, pp. 475–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Petri, A. M. Orbai, G. S. Alarcón et al., “Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 64, no. 8, pp. 2677–2686, 2012. View at Google Scholar
  8. F. M. Wigley, “Raynaud’s phenomen,” Current Opinion in Rheumatology, vol. 5, no. 6, pp. 773–784, 1993. View at Google Scholar
  9. N. Basu, R. Watts, I. Bajema et al., “EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis,” Annals of the Rheumatic Diseases, vol. 69, no. 10, pp. 1744–1750, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. F. van den Hoogen, D. Khanna, J. Fransen et al., “2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative,” Annals of the Rheumatic Diseases, vol. 72, no. 11, pp. 1747–1755, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mosca, C. Tani, S. Vagnani et al., “The diagnosis and classification of undifferentiated connective tissue diseases,” Journal of Autoimmunity, vol. 48-49, pp. 50–52, 2014. View at Publisher · View at Google Scholar
  12. J. A. Gómez-Puerta and R. Cervera, “Diagnosis and classification of the antiphospholipid syndrome,” Journal of Autoimmunity, vol. 48-49, pp. 20–25, 2014. View at Publisher · View at Google Scholar
  13. J. C. Milisenda and A. Selva-O'Callaghan, “The diagnosis and classification of polymyositis,” Journal of Autoimmunity, vol. 48-49, pp. 118–122, 2014. View at Google Scholar
  14. C. Tani, L. Carli, S. Vagnani et al., “The diagnosis and classification of mixed connective tissue disease,” Journal of Autoimmunity, vol. 48-49, pp. 46–49, 2014. View at Publisher · View at Google Scholar
  15. D. D. Gladman, C. Antoni, P. Mease, D. O. Clegg, and O. Nash, “Psoriatic arthritis: epidemiology, clinical features, course, and outcome,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. ii14–ii17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Congi and E. Roussou, “Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria,” Clinical and Experimental Rheumatology, vol. 28, no. 3, pp. 304–310, 2010. View at Google Scholar · View at Scopus
  17. J. M. Gelfand, R. S. Stern, T. Nijsten et al., “The prevalence of psoriasis in African Americans: results from a population-based study,” Journal of the American Academy of Dermatology, vol. 52, no. 1, pp. 23–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Draborg, K. Duus, and G. Houen, “Epstein-barr virus in systemic autoimmune diseases,” Clinical and Developmental Immunology, vol. 2013, Article ID 535738, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Lodolce, L. E. Kolodziej, L. Rhee et al., “African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity,” The Journal of Immunology, vol. 184, no. 12, pp. 7001–7009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. Lodolce, L. E. Kolodziej, L. Rhee et al., “African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity,” Journal of Immunology, vol. 184, no. 12, pp. 7001–7009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. S. Ramos, L. A. Criswell, K. L. Moser et al., “A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap,” PLoS Genetics, vol. 7, no. 12, Article ID e1002406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Adrianto, F. Wen, A. Templeton et al., “Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus,” Nature Genetics, vol. 43, no. 3, pp. 253–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Wu, T. U. Nguyen, K.-Y. T. Poon, and L. J. Herrinton, “The association of psoriasis with autoimmune diseases,” Journal of the American Academy of Dermatology, vol. 67, no. 5, pp. 924–930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. Bowcock, “The genetics of psoriasis and autoimmunity,” Annual Review of Genomics and Human Genetics, vol. 6, pp. 93–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. V. L. Williams and P. R. Cohen, “TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists,” International Journal of Dermatology, vol. 50, no. 5, pp. 619–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Bedoya, B. Lam, K. Lau, and J. Larkin III, “Th17 cells in immunity and autoimmunity,” Clinical and Developmental Immunology, vol. 2013, Article ID 986789, 16 pages, 2013. View at Publisher · View at Google Scholar
  27. M. A. Lowes, C. B. Russell, D. A. Martin, J. E. Towne, and J. G. Krueger, “The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses,” Trends in Immunology, vol. 34, no. 4, pp. 174–181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. F. B. Vincent, M. Northcott, A. Hoi, F. Mackay, and E. F. Morand, “Clinical associations of serum interleukin-17 in systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 15, no. 4, article R97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Cao, “Pivotal functions of plasmacytoid dendritic cells in systemic autoimmune pathogenesis,” Journal of Clinical & Cellular Immunology, vol. 5, no. 2, p. 212, 2014. View at Google Scholar
  30. S. H. Kassim, J. Jordan, J. Schreiter, S. Adhikarakunnathu, F. Baribaud, and L. San Mateo, “Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells,” Cellular Immunology, vol. 284, no. 1-2, pp. 119–128, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. L. Wright, H. B. Thomas, R. J. Moots, and S. W. Edwards, “Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy,” Rheumatology, 2014. View at Publisher · View at Google Scholar
  32. E. P. Prens, M. Kant, G. van Dijk, L. I. van der Wel, S. Mourits, and L. van der Fits, “IFN-α enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis,” Journal of Investigative Dermatology, vol. 128, no. 4, pp. 932–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Lu and V. Kakkar, “The role of Heat Shock Protein (HSP) in atherosclerosis: pathophysiology and clinical opportunities,” Current Medicinal Chemistry, vol. 17, no. 10, pp. 957–973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Siegel, S. Devaraj, A. Mitra, S. P. Raychaudhuri, S. K. Raychaudhuri, and I. Jialal, “Inflammation, atherosclerosis, and psoriasis,” Clinical Reviews in Allergy & Immunology, vol. 44, no. 2, pp. 194–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. H. Xie, A. P. Yamniuk, V. Borowski et al., “Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases,” Journal of Immunology, vol. 192, no. 9, pp. 4083–4092, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Conde, M. Scotece, R. Gómez et al., “Adipokines: Biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity,” Biofactors, vol. 37, no. 6, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. H. Costenbader and E. W. Karlson, “Cigarette smoking and autoimmune disease: what can we learn from epidemiology?” Lupus, vol. 15, no. 11, pp. 737–745, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. F. McCarty and J. J. DiNicolantonio, “The molecular biology and pathophysiology of vascular calcification,” Postgraduate Medicine, vol. 126, no. 2, pp. 54–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. T. A. Röhn, G. T. Jennings, M. Hernandez et al., “Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis,” European Journal of Immunology, vol. 36, no. 11, pp. 2857–2867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. F. de Carvalho, R. M. R. Pereira, and Y. Shoenfeld, “Vaccination for atherosclerosis,” Clinical Reviews in Allergy & Immunology, vol. 38, no. 2-3, pp. 135–140, 2010. View at Publisher · View at Google Scholar · View at Scopus